New Liver Cancer Study Findings Have Been Reported from Roger Williams Medical Center (Disparities In Hepatocellular Carcinoma Survival By Medicaid-status: a National Population-based Risk Analysis): Oncology – Liver Cancer

2023 MAY 17 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- Data detailed on Oncology - Liver Cancer have been presented. According to news reporting originating from Providence, Rhode Island, by NewsRx correspondents, research stated, “Previous studies have demonstrated disparities in survival surrounding hepatocellular carcinoma (HCC) across a variety of socio-demographic factors; however, the relationship between Medicaid-status and HCC survival is poorly understood. We constructed 5-year, disease-specific survival curves using the Kaplan-Meier method and performed an adjusted survival analysis using multivariate Cox-proportional hazard regression.”

Financial supporters for this research include NIH National Cancer Institute (NCI), Centers for Disease Control & Prevention - USA, California Department of Public Health.

Our news editors obtained a quote from the research from Roger Williams Medical Center, “We analyzed 17,059 non-elderly patients (12,194 non-Medicaid, 4875 Medicaid) diagnosed between 2006 and 2013 and found that Medicaid status was not associated with higher risk of diseases -specific death compared to other insurance types (p = .232, aHR 1.02, 95% CI: 0.983-1.07) after for controlling for a variety of co-variates (ie. marital status, urbanicity, etc.). We found no difference in the risk of death between patients enrolled in Medicaid for more than three years versus those enrolled for less than three years. In all models, rurality and unmarried status were also associated with an increased risk of death (aHR 1.11, 95% CI: 1.03-1.18, p = .002 and aHR 1.18, 95% CI: 1.13-1.23, p< .001, respectively).”

According to the news editors, the research concluded: “Those enrolled in Medicaid prior to HCC diagnosis may not be associated with a higher risk of disease-specific death compared to non-Medicaid enrolled patients.”

This research has been peer-reviewed.

For more information on this research see: Disparities In Hepatocellular Carcinoma Survival By Medicaid-status: a National Population-based Risk Analysis. European Journal of Surgical Oncology, 2023;49(4):794-801. European Journal of Surgical Oncology can be contacted at: Elsevier Sci Ltd, The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, Oxon, England.

The news editors report that additional information may be obtained by contacting Ponnandai S. Somasundar, Roger Williams Medical Center, Dept. of Surgical Oncology, Providence, RI, United States. Additional authors for this research include Eric J. Kim, Arjun Ganga, James Y. Lee, Roy S. Zawadzki, William Adriance, Rachel Wang and George Cholankeril.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1016/j.ejso.2022.12.001. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

(Our reports deliver fact-based news of research and discoveries from around the world.)